BVAXF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jun 5 closing price
Capitalization
8.58M
THTX
Price
$2.58
Change
-$0.05 (-1.90%)
Updated
Jun 6 closing price
Capitalization
118.3M
Interact to see
Advertisement

BVAXF vs THTX

Header iconBVAXF vs THTX Comparison
Open Charts BVAXF vs THTXBanner chart's image
BioVaxys Technology
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.84K
Capitalization8.58M
Theratechnologies
Price$2.58
Change-$0.05 (-1.90%)
Volume$96.21K
Capitalization118.3M
BVAXF vs THTX Comparison Chart
Loading...
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BVAXF vs. THTX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVAXF is a Hold and THTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BVAXF: $0.03 vs. THTX: $2.58)
Brand notoriety: BVAXF and THTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BVAXF: 4% vs. THTX: 3%
Market capitalization -- BVAXF: $8.58M vs. THTX: $118.3M
BVAXF [@Biotechnology] is valued at $8.58M. THTX’s [@Biotechnology] market capitalization is $118.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BVAXF’s FA Score shows that 0 FA rating(s) are green whileTHTX’s FA Score has 1 green FA rating(s).

  • BVAXF’s FA Score: 0 green, 5 red.
  • THTX’s FA Score: 1 green, 4 red.
According to our system of comparison, THTX is a better buy in the long-term than BVAXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

THTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • THTX’s TA Score: 4 bullish, 3 bearish.

Price Growth

BVAXF (@Biotechnology) experienced а -2.64% price change this week, while THTX (@Biotechnology) price change was -2.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BVAXF is expected to report earnings on Mar 31, 2025.

THTX is expected to report earnings on Apr 09, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
THTX($118M) has a higher market cap than BVAXF($8.58M). THTX YTD gains are higher at: 42.541 vs. BVAXF (-30.260). THTX has higher annual earnings (EBITDA): 10.1M vs. BVAXF (-4.13M). THTX has more cash in the bank: 4.34M vs. BVAXF (157K). BVAXF has less debt than THTX: BVAXF (67.7K) vs THTX (50.4M). THTX has higher revenues than BVAXF: THTX (88.7M) vs BVAXF (0).
BVAXFTHTXBVAXF / THTX
Capitalization8.58M118M7%
EBITDA-4.13M10.1M-41%
Gain YTD-30.26042.541-71%
P/E RatioN/AN/A-
Revenue088.7M-
Total Cash157K4.34M4%
Total Debt67.7K50.4M0%
FUNDAMENTALS RATINGS
BVAXF vs THTX: Fundamental Ratings
BVAXF
THTX
OUTLOOK RATING
1..100
549
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6136
P/E GROWTH RATING
1..100
1001
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BVAXF's Valuation (40) in the null industry is somewhat better than the same rating for THTX (100). This means that BVAXF’s stock grew somewhat faster than THTX’s over the last 12 months.

BVAXF's Profit vs Risk Rating (100) in the null industry is in the same range as THTX (100). This means that BVAXF’s stock grew similarly to THTX’s over the last 12 months.

BVAXF's SMR Rating (99) in the null industry is in the same range as THTX (100). This means that BVAXF’s stock grew similarly to THTX’s over the last 12 months.

THTX's Price Growth Rating (36) in the null industry is in the same range as BVAXF (61). This means that THTX’s stock grew similarly to BVAXF’s over the last 12 months.

THTX's P/E Growth Rating (1) in the null industry is significantly better than the same rating for BVAXF (100). This means that THTX’s stock grew significantly faster than BVAXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
THTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
THTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBVRX27.420.36
+1.33%
William Blair Small Cap Value R6
DODGX266.252.83
+1.07%
Dodge & Cox Stock I
FRVLX53.29N/A
N/A
Franklin Small Cap Value A
CAVAX16.23N/A
N/A
SEI Catholic Values Equity F (SCVT)
COMZX27.73N/A
N/A
DWS Digital Horizons Inst

BVAXF and

Correlation & Price change

A.I.dvisor tells us that BVAXF and GSGTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BVAXF and GSGTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BVAXF
1D Price
Change %
BVAXF100%
N/A
GSGTF - BVAXF
29%
Poorly correlated
N/A
THTX - BVAXF
24%
Poorly correlated
-1.90%
EDSA - BVAXF
21%
Poorly correlated
-6.63%
CSBR - BVAXF
21%
Poorly correlated
+6.00%
SQZB - BVAXF
14%
Poorly correlated
-6.67%
More

THTX and

Correlation & Price change

A.I.dvisor tells us that THTX and IDYA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THTX and IDYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THTX
1D Price
Change %
THTX100%
-1.90%
IDYA - THTX
27%
Poorly correlated
+2.99%
GNPX - THTX
27%
Poorly correlated
+5.43%
CSLLY - THTX
26%
Poorly correlated
-0.15%
THRD - THTX
26%
Poorly correlated
N/A
SCPH - THTX
25%
Poorly correlated
+2.19%
More